Tech Policy
CDC weighs $1.6M for newborn hepatitis B trial amid ethics outcry
New reporting says the CDC weighs funding a trial criticized as unethical that could expose newborns in Guinea-Bissau to hepatitis B.
New reporting says the CDC weighs funding a trial criticized as unethical that could expose newborns in Guinea-Bissau to hepatitis B.
The Daily Brief
Every morning, the news that matters from AI, phones, apps and the people shaping tech. Explained in plain English. Free.
One email a day. No spam, unsubscribe anytime. Privacy policy